Piribo: PharmaVitae 2004: GlaxoSmithKline Global Analysis
Piribo, the online destination for business intelligence for the biopharma industry, has added a key pharmaceutical company intelligence report to its collection.
LONDON, UK (PRWEB) September 24, 2004
GlaxoSmithKline Global Analysis examines the current position and future outlook for GlaxoSmithKline (‘GSK’) in the ethical pharmaceutical sector. It considers why GSK’s position as the second largest ethical pharmaceutical company is under threat and benchmarks GSK's performance against key rivals in the ethical pharmaceuticals sector. The report provides detailed information about R&D pipelines and forecast sales for each major therapy area for the period to 2010, identifying the key growth drivers in GSK's pipeline.
For big pharmaceutical companies such as GSK, declining R&D productivity and competition from newly created mega-players is set against a backdrop of pressure from healthcare authorities to cut drug prices and initiatives to ease the passage of generics to market.
The reportÂ’s author, Datamonitor, find that as return on investment and opportunities throughout the pharmaceutical value chain decline, the need to stay ahead of the competition is paramount. With companies facing saturation in their home markets, geographical expansion is forming a key part of their strategy, with major US and European players setting themselves high targets for growth in Japan, whilst at the same time the Japanese pharmaceutical companies are all striving for US and European expansion.
This 160-page report contains:
• A 150 page profile analyzing the company's strategy, market position, alliance network, financial health and portfolio and pipeline, with all key drugs analyzed and forecast through to 2010;
• An Excel-based Interactive Analysis Tool containing future-focused data on product, strategy and financial information;
• A PowerPoint slide pack detailing all key figures relating to the company in a fully exportable format.
PharmaVitae 2004: GlaxoSmithKline Global Analysis is available from Piribo. For more information visit http://www. piribo. com/publications/company/glaxosmithkline/glaxo_global_2004.html (http://www. piribo. com/publications/company/glaxosmithkline/glaxo_global_2004.html)
About Piribo.
Piribo is the source for information products concerning the global biotechnology and pharmaceutical industries and contains details of hundreds of business information studies, market reports and books. Piribo has ongoing relationships with leading market research and publishing companies, so we can offer a current and comprehensive range of specialised intelligence.
###
